90 related articles for article (PubMed ID: 23163701)
21. PGE
Amberger DC; Doraneh-Gard F; Gunsilius C; Weinmann M; Möbius S; Kugler C; Rogers N; Böck C; Ködel U; Werner JO; Krämer D; Eiz-Vesper B; Rank A; Schmid C; Schmetzer HM
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533251
[TBL] [Abstract][Full Text] [Related]
22. Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DC
Ansprenger C; Amberger DC; Schmetzer HM
Clin Immunol; 2020 Aug; 217():108467. PubMed ID: 32464186
[TBL] [Abstract][Full Text] [Related]
23. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077
[TBL] [Abstract][Full Text] [Related]
24. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
25. Volatile Phases Derived from Serum, DC, or MLC Culture Supernatants to Deduce a VOC-Based Diagnostic Profiling Strategy for Leukemic Diseases.
Baudrexler T; Boeselt T; Li L; Bohlscheid S; Boas U; Schmid C; Rank A; Schmohl J; Koczulla R; Schmetzer HM
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371569
[TBL] [Abstract][Full Text] [Related]
26. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
Bontkes HJ; Ruizendaal JJ; Kramer D; Santegoets SJ; Scheper RJ; de Gruijl TD; Meijer CJ; Hooijberg E
J Immunother; 2006; 29(2):188-200. PubMed ID: 16531819
[TBL] [Abstract][Full Text] [Related]
27. In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping.
Reuther S; Schmetzer H; Schuster FR; Krell P; Grabrucker C; Liepert A; Kroell T; Kolb HJ; Borkhardt A; Buhmann R
Clin Exp Med; 2013 Feb; 13(1):29-48. PubMed ID: 22441559
[TBL] [Abstract][Full Text] [Related]
28. [T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission].
He X; You S; Bian S
Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):629-32. PubMed ID: 16200709
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.
Brady MT; Miller A; Sait SN; Ford LA; Minderman H; Wang ES; Lee KP; Baumann H; Wetzler M
Leuk Res; 2013 Jul; 37(7):822-8. PubMed ID: 23628554
[TBL] [Abstract][Full Text] [Related]
30. The in-vitro generation of dendritic cells from blast cells in acute leukaemia.
Robinson SP; English N; Jaju R; Kearney L; Knight SC; Reid CD
Br J Haematol; 1998 Dec; 103(3):763-71. PubMed ID: 9858228
[TBL] [Abstract][Full Text] [Related]
31. The induction and function study on dendritic cells derived from blasts from patients with acute myelogenous leukemia.
Meng DM; Zhao CT; Wu SL; Wang BZ; Lü ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):625-31. PubMed ID: 15498123
[TBL] [Abstract][Full Text] [Related]
32. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.
Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J
Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860
[TBL] [Abstract][Full Text] [Related]
33. In vitro interactions between gamma deltaT cells, DC, and CD4+ T cells; implications for the immunotherapy of leukemia.
Ye Z; Haley S; Gee AP; Henslee-Downey PJ; Lamb LS
Cytotherapy; 2002; 4(3):293-304. PubMed ID: 12194726
[TBL] [Abstract][Full Text] [Related]
34. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
[TBL] [Abstract][Full Text] [Related]
35. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF
Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029
[TBL] [Abstract][Full Text] [Related]
36. Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia.
Serrano-López J; Sanchez-Garcia J; Serrano J; Alvarez-Rivas MA; Garcia-Castellano JM; Roman-Gomez J; de la Rosa O; Herrera-Arroyo C; Torres-Gomez A
Transfusion; 2011 Jul; 51(7):1546-55. PubMed ID: 21303373
[TBL] [Abstract][Full Text] [Related]
37. Generation of dendritic cells from acute myeloid leukaemia cells and monocytes: our local experience.
Lim MN; Leong CF; Cheong SK; Seow HF
Malays J Pathol; 2003 Dec; 25(2):107-12. PubMed ID: 16196366
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Moldenhauer A; Frank RC; Pinilla-Ibarz J; Holland G; Boccuni P; Scheinberg DA; Salama A; Seeger K; Moore MA; Nimer SD
J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
[TBL] [Abstract][Full Text] [Related]
39. [Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA].
Ge W; You SG; Wang YF; Li CH; Liu XF; He XP; Ma S; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):461-4. PubMed ID: 16383235
[TBL] [Abstract][Full Text] [Related]
40. Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy.
Fischbacher D; Merle M; Liepert A; Grabrucker C; Kroell T; Kremser A; Dreyßig J; Freudenreich M; Schuster F; Borkhardt A; Kraemer D; Koehne CH; Kolb HJ; Schmid C; Schmetzer HM
Cell Commun Adhes; 2015; 22(2-6):49-65. PubMed ID: 27602789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
